SANEGENE BIO
SANEGENE BIO
Industry:
Biopharma Health Care Medical
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Status:
Active
Total Funding:
38 M USD
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Sanegene Bio
More informations about "Sanegene Bio"
SanegeneBio
Sanegene Announced First-in-Human Phase I Clinical Data for C3-Targeting siRNA Drug SGB-9768 at the 8th Complement-Based Drug Development Summit Aug. 06, 2024 SanegeneBio โฆSee details»
About Us - SanegeneBio
SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by the cutting-edge delivery technology.See details»
Sanegene Bio - Crunchbase Company Profile & Funding
Organization. Sanegene Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Sanegene โฆSee details»
Sanegene Bio 2025 Company Profile: Valuation, โฆ
Mar 12, 2022 Sanegene Bio General Information Description. Developer of RNA interference (RNAi) therapeutics designed to knock down disease-causing genes. The company's products are constructed and developed with RNA technology โฆSee details»
Sanegene Bio - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
SanegeneBio Raised nearly $100 Million in Series A+ Financing โฆ
With the excellent leadership of the team, Sanegene is expected to quickly grow into an international industry leader. K2 Venture Partners said that, it is an honor to lead the early โฆSee details»
Sanegene Bio USA Inc - CEO and Investor Conference 2025
March 2-3, 2026ใปMiami, FL. Home; About. Event Overview; 2025 Schedule at a Glance; 2025 Event Preview WebinarSee details»
Sanegene Bio - Crunchbase
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new โฆSee details»
Sanegene Bio Usa, Inc. - Drug pipelines, Patents, Clinical trials
Jan 23, 2025 Explore Sanegene Bio Usa, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, Technology Platform:siRNA, Drug:SGB-3908, DSGB-3908. ... The statistics โฆSee details»
Sanegene Bio - Org Chart, Teams, Culture & Jobs - The โฆ
View Sanegene Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Sanegene Bio USA Inc - BIO Investor Forum 2024
Sanegene Bio USA Inc | Biotech or pharma, therapeutic R&D Address Boston Massachusetts United States Contact Exhibitor. Full Name * Email Address * Contact Message * ... More BIO โฆSee details»
Sanegene Bio - Products, Competitors, Financials, Employees ...
Sanegene Bio is a biotechnology company focused on the development of RNA interference (RNAi) therapeutics within the biopharmaceutical industry. The company develops RNAi โฆSee details»
SanegeneBio - Work in biotech
SanegeneBio is developing RNA interference (RNAi) therapeutics for unmet clinical needs. RNAi triggers the gene silencing to reduce the protein production of specific targets by leveraging an โฆSee details»
Sanegene Bio - Updates, News, Events, Signals & Triggers
Sanegene Bio may be growing as it has entered into a strategic collaboration to develop an siRNA drug for the treatment of hypertension, indicating an expansion of its research and โฆSee details»
Sanegene Bio USA Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sanegene Bio USA Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Sanegene Bio Usa, Inc. (Sanegene Bio Usa, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
SAN FRANSCISO and SUZHOU, China, Aug. 1, 2024. Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures and commercializes โฆSee details»
Series A - Sanegene Bio - 2022-11-29 - Crunchbase
Nov 29, 2022 Organization Name . Sanegene Bio . Announced Date Nov 29, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Lead Investors. Edit Lead Investors โฆSee details»
Sanegene Bio Company Profile: Overview and Full News Analysis
Sanegene Bio has also secured significant funding, with nearly $100 million raised in Series A+ financing led by Tencent Investment and Yuanbio Venture Capital. Notably, Sanegene Bio โฆSee details»
Exploring the Latest AGT siRNA Deal by Sanegene Bio (Suzhou): A โฆ
Jan 13, 2024 On December 27, 2023, Innovent Biologics, Inc. and Sanegene Bio (Suzhou) Co., Ltd. jointly announced that they have entered into a strategic collaboration agreement to co โฆSee details»
Sanegene Bio - Contacts, Employees, Board Members
Organization. Sanegene Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 3. โฆSee details»